Eplontersen approved to treat adults with rare inherited nerve disease or polyneuropathy

Eplontersen approved to treat adults with rare inherited nerve disease or polyneuropathy

Eplontersen approved to treat adults with rare inherited nerve disease or polyneuropathy

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (Wainzua) to treat adults with polyneuropathy associated with hereditary transthyretin amyloidosis (ATTRv), which is a rare progressive …

HM GovernmentSource

Previus Post
Environment Agency
Next Post
Louise Smyth

Leave a comment